Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Danaher Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 9
Danaher Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 10
Danaher Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 11
Danaher Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 12
Danaher Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 13
Danaher Corp, Medical Equipment, Deal Details 18
Asset Purchase 18
Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 18
Devicor Medical Products Acquires Hydromark Breast Biopsy Marker Portfolio And Related Assets From Biopsy Sciences 20
Venture Financing 21
H2O TECH Secures Investment In Venture Financing 21
Partnerships 22
Leica Biosystems Enters into Licensing Agreement with Arno Therapeutics 22
Cell Signaling Technology Enters Into Licensing Agreement With Cepheid For Personalized Cancer Diagnostics 23
Smart Imaging Enters Into Licensing Agreement With Leica Microsystems 24
Prosolia Enters Into Licensing Agreement With AB Sciex For ORNL Analytical Technology 25
Thermo Fisher and Leica Microsystems Enter into Partnership 26
AB Sciex Enters into Co-Marketing Agreement with IROA Technologies 27
Leica Biosystems Enters into Distribution Agreement with Kub Technologies 28
Clearbridge Enters into Agreement with Leica Biosystems 29
Clearbridge BioMedics and Leica Biosystems Enter into Co-Marketing Partnership 30
SCIEX forms Joint Venture with Zhejiang Dian Diagnostics in China 31
Nobel Biocare Enters into Agreement with Dentalpoint 32
Grifols and Beckman Coulter Enter into Distribution Agreement 33
SpeeDx Enters into Distribution Agreement with Cepheid 34
Bayer Enters into Co-Development Agreement with Leica Biosystems 35
Novacyt Enters into Partnership with Cepheid 36
DiaSorin Enters into Agreement with Beckman Coulter 37
Devicor Medical Products Enters into Distribution Agreement with Endomagnetics 38
Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 39
AB Sciex Enters into Agreement with QPS Holdings 40
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 41
Cepheid, MedImmune and Combacte Enter into Agreement 42
AB Sciex Enters into Co-Marketing Agreement with Pressure BioSciences 43
Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 44
Sidney Kimmel Cancer Center Enters into Agreement with Cepheid 45
RareCyte Enters into Co-Marketing Agreement with Leica Biosystems 46
Vomaris Innovations Enters into Distribution Agreement with Metrex Research 47
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 48
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 49
NanoCellect Biomedical Enters into Co-Development Agreement with Invetech 50
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 51
NeoStem Enters into Co-Development Agreement with Invetech 52
Leica Biosystems Nussloch Partners with NovoPath 53
Leica Biosystems Nussloch Partners with Mayo Clinic 54
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 55
Ab Sciex Enters into Co-Development Agreement with Dalton Pharma 56
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 57
Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb 58
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 59
Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 60
Invetech Enters Into Co-Development Agreement With Biocartis For Evalution 61
Arno Therapeutics Enters Into Co-Development Agreement With Leica Biosystems 62
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 63
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 64
Leica Biosystems Enters Into Agreement With Aspera For Data Distribution Solution 65
CellaVision Expands Distribution Agreement With Beckman Coulter 66
Leica Biosystems And Synthon Biopharma Enter Into Agreement To Develop Companion Diagnostic Test For Targeted Cancer Therapies 67
Cepheid Enters Into Co-Development Agreement With Oregon Health and Science University 68
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 69
IRIS International Enters Into Distribution Agreement With Alifax 70
Leica Microsystems Enters Into Integration Agreement With Indica Labs 71
Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 72
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 73
Devicor Medical Products Enters Into Co-Marketing Agreement With Carbon Medical Technologies 74
Iris International Enters Into Distribution Agreement With Fisher HealthCare 75
Merger 76
Molecular Devices and ForteBio Complete Merger to Form Biologics Solutions 76
Equity Offering 77
Danaher Plans to Raise Funds through Public Offering of Securities 77
Debt Offering 78
Danaher Raises USD279.8 Million in Public Offering of Floating Rate Notes Due 2022 78
Danaher Raises USD671.6 Million in Public Offering of 1.2% Notes Due 2027 80
Danaher Raises USD500 Million in Public Offering of 1.65% Notes Due 2018 82
Danaher Raises USD500 Million in Public Offering of 3.35% Notes Due 2025 84
Danaher Raises USD500 Million in Public Offering of 2.4% Notes Due 2020 86
Danaher Raises USD500 Million in Public Offering of 4.375% Notes Due 2045 88
Danaher Raises USD500 Million in Public Offering of Notes Due 2017 90
Danaher Raises USD671 Million in Public Offering of 1% Notes Due 2019 92
Danaher Raises USD894.5 Million in Public Offering of 2.5% Notes Due 2025 94
Danaher Raises USD894.5 Million in Public Offering of 1.7% Notes Due 2022 96
Cepheid Completes Private Placement Of Notes Due 2021 For US$345 Million 98
Asset Transactions 100
GENEWIZ to Acquire Genomic Services Business of Beckman Coulter 100
Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For US$551 Million 101
Acquisition 103
Danaher to Acquire Integrated DNA Technologies 103
Danaher Acquires Phenomenex 104
Danaher Acquires Cepheid 105
Danaher Acquires Pall for USD13.8 Billion 107
Leica Microsystems to Acquire Bioptigen 109
Danaher Acquires 97% Stake in Nobel Biocare for USD2.17 Billion in Tender Offer 110
Leica Biosystems Nussloch Acquires Devicor Medical from GTCR 112
Leica Biosystems Acquires Kreatech Diagnostics 113
Leica Microsystems And Leica Biosystems Acquire Aotec Instrumentos 114
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 115
Danaher Completes Acquisition Of 91.6% Stake In Iris International, Diagnostic Test Maker, For US$324 Million 117
Leica Biosystems Completes Acquisition Of Aperio Technologies 119
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 121
Pall Corporation Completes Acquisition Of ForteBio For US$142.5 Million 122
Danaher Corp – Key Competitors 124
Danaher Corp – Key Employees 125
Danaher Corp – Locations And Subsidiaries 126
Head Office 126
Other Locations & Subsidiaries 126
Business Unit 133
Recent Developments 134
Financial Announcements 134
Apr 19, 2018: Danaher Announces First Quarter 2018 Results 134
Mar 07, 2018: Danaher Provides Update on First Quarter 2018 Financial Performance 135
Jan 30, 2018: Danaher Reports Fourth Quarter And Full Year 2017 Results 136
Oct 19, 2017: Danaher Reports Third Quarter 2017 Results 137
Jul 20, 2017: Danaher Reports Second Quarter 2017 Results 138
Apr 20, 2017: Danaher Reports First Quarter 2017 Results 139
Jan 31, 2017: Danaher Reports Fourth Quarter And Full Year 2016 Results 140
Corporate Communications 141
Apr 25, 2018: Diebold Nixdorf Elects Board Members At Annual Shareholders Meeting 141
Jan 20, 2018: Danaher Announces Transition Plan for Chief Financial Officer 142
Nov 28, 2017: Danaher Announced its Leadership Appointment 143
Feb 21, 2017: Danaher Announces Appointment Of Raymond C. Stevens, Ph.D. To Danaher Board 144
Legal and Regulatory 145
Jul 19, 2018: Danaher announces plan to Spin off dental business into an independent, publicly traded company 145
Appendix 146
Methodology 146
About GlobalData 146
Contact Us 146
Disclaimer 146
Danaher Corp, Medical Equipment, Key Facts, 2017 2
Danaher Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Danaher Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 9
Danaher Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 10
Danaher Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 11
Danaher Corp, Deals By Market, 2012 to YTD 2018 12
Danaher Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 13
Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 18
Devicor Medical Products Acquires Hydromark Breast Biopsy Marker Portfolio And Related Assets From Biopsy Sciences 20
H2O TECH Secures Investment In Venture Financing 21
Leica Biosystems Enters into Licensing Agreement with Arno Therapeutics 22
Cell Signaling Technology Enters Into Licensing Agreement With Cepheid For Personalized Cancer Diagnostics 23
Smart Imaging Enters Into Licensing Agreement With Leica Microsystems 24
Prosolia Enters Into Licensing Agreement With AB Sciex For ORNL Analytical Technology 25
Thermo Fisher and Leica Microsystems Enter into Partnership 26
AB Sciex Enters into Co-Marketing Agreement with IROA Technologies 27
Leica Biosystems Enters into Distribution Agreement with Kub Technologies 28
Clearbridge Enters into Agreement with Leica Biosystems 29
Clearbridge BioMedics and Leica Biosystems Enter into Co-Marketing Partnership 30
SCIEX forms Joint Venture with Zhejiang Dian Diagnostics in China 31
Nobel Biocare Enters into Agreement with Dentalpoint 32
Grifols and Beckman Coulter Enter into Distribution Agreement 33
SpeeDx Enters into Distribution Agreement with Cepheid 34
Bayer Enters into Co-Development Agreement with Leica Biosystems 35
Novacyt Enters into Partnership with Cepheid 36
DiaSorin Enters into Agreement with Beckman Coulter 37
Devicor Medical Products Enters into Distribution Agreement with Endomagnetics 38
Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 39
AB Sciex Enters into Agreement with QPS Holdings 40
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 41
Cepheid, MedImmune and Combacte Enter into Agreement 42
AB Sciex Enters into Co-Marketing Agreement with Pressure BioSciences 43
Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 44
Sidney Kimmel Cancer Center Enters into Agreement with Cepheid 45
RareCyte Enters into Co-Marketing Agreement with Leica Biosystems 46
Vomaris Innovations Enters into Distribution Agreement with Metrex Research 47
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 48
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 49
NanoCellect Biomedical Enters into Co-Development Agreement with Invetech 50
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 51
NeoStem Enters into Co-Development Agreement with Invetech 52
Leica Biosystems Nussloch Partners with NovoPath 53
Leica Biosystems Nussloch Partners with Mayo Clinic 54
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 55
Ab Sciex Enters into Co-Development Agreement with Dalton Pharma 56
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 57
Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb 58
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 59
Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 60
Invetech Enters Into Co-Development Agreement With Biocartis For Evalution 61
Arno Therapeutics Enters Into Co-Development Agreement With Leica Biosystems 62
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 63
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 64
Leica Biosystems Enters Into Agreement With Aspera For Data Distribution Solution 65
CellaVision Expands Distribution Agreement With Beckman Coulter 66
Leica Biosystems And Synthon Biopharma Enter Into Agreement To Develop Companion Diagnostic Test For Targeted Cancer Therapies 67
Cepheid Enters Into Co-Development Agreement With Oregon Health and Science University 68
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 69
IRIS International Enters Into Distribution Agreement With Alifax 70
Leica Microsystems Enters Into Integration Agreement With Indica Labs 71
Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 72
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 73
Devicor Medical Products Enters Into Co-Marketing Agreement With Carbon Medical Technologies 74
Iris International Enters Into Distribution Agreement With Fisher HealthCare 75
Molecular Devices and ForteBio Complete Merger to Form Biologics Solutions 76
Danaher Plans to Raise Funds through Public Offering of Securities 77
Danaher Raises USD279.8 Million in Public Offering of Floating Rate Notes Due 2022 78
Danaher Raises USD671.6 Million in Public Offering of 1.2% Notes Due 2027 80
Danaher Raises USD500 Million in Public Offering of 1.65% Notes Due 2018 82
Danaher Raises USD500 Million in Public Offering of 3.35% Notes Due 2025 84
Danaher Raises USD500 Million in Public Offering of 2.4% Notes Due 2020 86
Danaher Raises USD500 Million in Public Offering of 4.375% Notes Due 2045 88
Danaher Raises USD500 Million in Public Offering of Notes Due 2017 90
Danaher Raises USD671 Million in Public Offering of 1% Notes Due 2019 92
Danaher Raises USD894.5 Million in Public Offering of 2.5% Notes Due 2025 94
Danaher Raises USD894.5 Million in Public Offering of 1.7% Notes Due 2022 96
Cepheid Completes Private Placement Of Notes Due 2021 For US$345 Million 98
GENEWIZ to Acquire Genomic Services Business of Beckman Coulter 100
Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For US$551 Million 101
Danaher to Acquire Integrated DNA Technologies 103
Danaher Acquires Phenomenex 104
Danaher Acquires Cepheid 105
Danaher Acquires Pall for USD13.8 Billion 107
Leica Microsystems to Acquire Bioptigen 109
Danaher Acquires 97% Stake in Nobel Biocare for USD2.17 Billion in Tender Offer 110
Leica Biosystems Nussloch Acquires Devicor Medical from GTCR 112
Leica Biosystems Acquires Kreatech Diagnostics 113
Leica Microsystems And Leica Biosystems Acquire Aotec Instrumentos 114
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 115
Danaher Completes Acquisition Of 91.6% Stake In Iris International, Diagnostic Test Maker, For US$324 Million 117
Leica Biosystems Completes Acquisition Of Aperio Technologies 119
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 121
Pall Corporation Completes Acquisition Of ForteBio For US$142.5 Million 122
Danaher Corp, Key Competitors 124
Danaher Corp, Key Employees 125
Danaher Corp, Other Locations 126
Danaher Corp, Subsidiaries 126
Danaher Corp, Business Unit 133
List of Figures
Danaher Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Danaher Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Danaher Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Danaher Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Danaher Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 9
Danaher Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 10
Danaher Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 11
Danaher Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 12
【免責事項】
http://www.globalresearch.jp/disclaimer